Ranjbar, S., Edraki, N., Khoshneviszadeh, M., Foroumadi, A., Miri, R., & Khoshneviszadeh, M. (2018). Design, synthesis, cytotoxicity evaluation and docking studies of 1,2,4-triazine derivatives bearing different arylidene-hydrazinyl moieties as potential mTOR inhibitors. Res Pharm Sci.
Citação norma ChicagoRanjbar, Sara, Najmeh Edraki, Mahsima Khoshneviszadeh, Alireza Foroumadi, Ramin Miri, and Mehdi Khoshneviszadeh. "Design, Synthesis, Cytotoxicity Evaluation and Docking Studies of 1,2,4-triazine Derivatives Bearing Different Arylidene-hydrazinyl Moieties As Potential MTOR Inhibitors." Res Pharm Sci 2018.
MLA citiranjeRanjbar, Sara, et al. "Design, Synthesis, Cytotoxicity Evaluation and Docking Studies of 1,2,4-triazine Derivatives Bearing Different Arylidene-hydrazinyl Moieties As Potential MTOR Inhibitors." Res Pharm Sci 2018.